Comparison of Emla cream and Cold on the injection site pain in Enoxapari
Not Applicable
- Conditions
- Injection pain.Acute pain
- Registration Number
- IRCT2013100914956N1
- Lead Sponsor
- Shahid Sadoughi University of Medical Sciences Yazd, School of Nursing & Midwifery
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 53
Inclusion Criteria
age between 18-65 years old; full consciousness; ability to communicate; not a severe pain in other areas; no history of prescribed Enoxaparin; no scarring and lesions at the injection site and no history of allergy to lidocaine & Prilocain.
Exclusion criteria: loss of consciousness; sensorimotor disorders; injection of other drug in the abdomen during the study, and two days before the study; prescription of narcotic and non-narcotic analgesics 2 hours before injection; allergy to EMLA cream; the development of diabetic neuropathy.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Injection pain. Timepoint: Immediate,5 &10 minute after injection. Method of measurement: Using the VAS scale & record severe pain intensity.
- Secondary Outcome Measures
Name Time Method